Pedro Paulo Vissotto de Paiva Diniz

Pedro Paulo Vissotto de Paiva Diniz

Auto-generated profile, based on publicly available information

Pedro Paulo Vissotto de Paiva Diniz

Western University of Health Sciences, Pomona, California, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2015 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
LPLuiza Helena Urso Pitassi
Luiza Helena Urso Pitassi
PDPedro Paulo Vissotto De Paiva Diniz
Pedro Paulo Vissotto De Paiva Diniz
DSDiana Gerardi Scorpio
Diana Gerardi Scorpio
MDMarina Rovani Drummond
Marina Rovani Drummond
BLBruno Grosselli Lania
Bruno Grosselli Lania
PVPaulo Eduardo Neves Ferreira Velho
Paulo Eduardo Neves Ferreira Velho
Bartonella species are blood-borne, re-emerging organisms, capable of causing prolonged infection with diverse disease manifestations, from asymptomatic bacteremia to chronic debilitating disease and death. This pathogen can survive for over a month in stored blood. However, its prevalence among blood donors is unknown, and screening of blood supplies for this pathogen is not routinely performed. We investigated Bartonella spp. prevalence in 500 blood donors from Campinas, Brazil, based on a cross-sectional design. Blood samples were inoculated into an enrichment liquid growth medium and sub-inoculated onto blood agar. Liquid culture samples and Gram-negative isolates were tested using a genus specific ITS PCR with amplicons sequenced for species identification. Bartonella henselae and Bartonella quintana antibodies were assayed by indirect immunofluorescence. B. henselae was isolated from six donors (1.2%). Sixteen donors (3.2%) were Bartonella-PCR positive after culture in liquid or on solid media, with 15 donors infected with B. henselae and one donor infected with Bartonella clarridgeiae. Antibodies against B. henselae or B. quintana were found in 16% and 32% of 500 blood donors, respectively. Serology was not associated with infection, with only three of 16 Bartonella-infected subjects seropositive for B. henselae or B. quintana. Bartonella DNA was present in the bloodstream of approximately one out of 30 donors from a major blood bank in South America. Negative serology does not rule out Bartonella spp. infection in healthy subjects. Using a combination of liquid and solid cultures, PCR, and DNA sequencing, this study documents for the first time that Bartonella spp. bacteremia occurs in asymptomatic blood donors. Our findings support further evaluation of Bartonella spp. transmission which can occur through blood transfusions. Bartonella is a genus of small bacteria with worldwide distribution, transmitted by blood-sucking insects, and is capable of causing disease in humans and animals. Some of the clinical presentations of Bartonella spp., such as cat scratch disease, trench fever, and bacillary angiomatosis are well documented; however, novel presentations have been described in the last two decades, ranging from cyclic flu-like syndrome to neurologic disease and life-threatening endocarditis. Asymptomatic human infection is possible and accidental blood transmission has been reported. Bacterium isolation is very difficult because they grow slowly and require special culture media and procedures. Serology testing poorly predicts active Bartonella infection, except in infection of cardiac valves. Therefore, diagnosis is generally challenging. However, when molecular detection techniques are coupled with special culture protocols, enhanced sensitivity and specificity can be achieved. We investigated Bartonella spp. infection prevalence in a large blood donor population and confirmed bacteremia in 1.2% of the subjects. Bloodstream infection was detected with at least three different molecular methods in 3.2% of donors. These results indicate that Bartonella is a genus of importance for transfusion medicine.

1 May 2011 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
PDPedro Paulo V. P. Diniz
Pedro Paulo V. P. Diniz
BSBianka S. Schulz
Bianka S. Schulz
KHKatrin Hartmann
Katrin Hartmann
Edward BreitschwerdtEdward Breitschwerdt
Edward Breitschwerdt
“ Candidatus Neoehrlichia mikurensis” is a new intracellular pathogen associated with human infection and death. “ Candidatus Neoehrlichia mikurensis” infection in a chronically neutropenic dog from Germany was confirmed by DNA sequencing. The same organism was previously described from ticks and two sick human beings from Germany.

1 May 2018 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
MDMarina Rovani Drummond
Marina Rovani Drummond
BLBruno Grosselli Lania
Bruno Grosselli Lania
PDPedro Paulo Vissotto de Paiva Diniz
Pedro Paulo Vissotto de Paiva Diniz
RGRovilson Gilioli
Rovilson Gilioli
DDDaniele Masselli Rodrigues Demolin
Daniele Masselli Rodrigues Demolin
PVPaulo Eduardo Neves Ferreira Velho
Paulo Eduardo Neves Ferreira Velho
Bartonella spp. are bacteria of worldwide distribution that cause asymptomatic to fatal infections in animals and humans. The most common zoonotic species is Bartonella henselae , for which cats are the major natural reservoir host. To better understand Bartonella sp. diagnostic limitations, we determined the frequency of bloodstream infection in 112 cats by comparing and combining the results of multiple conventional and nested PCRs from blood and liquid culture samples. Using liquid culture conventional PCR, Bartonella sp. DNA was amplified from 27.7% of samples (31/112) compared to 90.2% of samples (101/112) by combining nested PCR from blood and liquid culture, indicating that PCR testing of more than one type of sample provides better sensitivity than a standalone PCR and that bloodstream infection is very frequent among cats in southeastern Brazil. This study reinforces the need for multistep testing for Bartonella sp. infection to prevent false-negative diagnostic results, even in reservoir hosts such as cats that typically maintain higher bacteremia levels.

1 January 2015 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
GVGislaine Vieira-Damiani
Gislaine Vieira-Damiani
PDPedro Paulo Vissotto de Paiva Diniz
Pedro Paulo Vissotto de Paiva Diniz
LPLuiza Helena Urso Pitassi
Luiza Helena Urso Pitassi
SSStanley Sowy
Stanley Sowy
DSDiana Gerardi Scorpio
Diana Gerardi Scorpio
PVPaulo Eduardo Neves Ferreira Velho
Paulo Eduardo Neves Ferreira Velho
Human exposure to Bartonella clarridgeiae has been reported only on the basis of antibody detection. We report for the first time an asymptomatic human blood donor infected with B. clarridgeiae , as documented by enrichment blood culture, PCR, and DNA sequencing.

1 January 2007 in Ultrastructural Pathology
Verified
Journal Article
Closed access
PVPaulo Velho
Paulo Velho
VPVanessa Pimentel
Vanessa Pimentel
GNGilda Maria Barbaro Del Negro
Gilda Maria Barbaro Del Negro
TOThelma Suely Okay
Thelma Suely Okay
PDPedro Paulo Vissotto de Paiva Diniz
Pedro Paulo Vissotto de Paiva Diniz
Edward BreitschwerdtEdward Breitschwerdt
Edward Breitschwerdt
Bartonella spp. constitute emerging pathogens of worldwide distribution. Bacillary angiomatosis is the most frequent skin manifestation of bartonelloses; nevertheless, B. henselae infection should always be considered systemic, especially in immunodeficient individuals. The authors report the case of an AIDS patient with bacillary angiomatosis, who had concurrent severe anemia, hepatitis, peritonitis, pleuritis, and pericarditis. Clinical manifestation, electronic microscopic examination of erythrocytes, and histopathology of a papule biopsy suggested a Bartonella sp. infection. Multiple genes were target by PCR and B. henselae DNA was amplified and sequenced (GenBank accession number EF196804) from the angiomatous papule. Treatment with clarithromycin resulted in resolution of the bacillary angiomatosis, fever, anemia, panserosites, and hepatitis.

18 June 2026 in Journal of Shelter Medicine and Community Animal Health
Verified
Journal Article
Open access
JCJonathan Chapman
Jonathan Chapman
APAntoinette Piraino
Antoinette Piraino
KMKelly Min
Kelly Min
PDPedro P.V.P. Diniz
Pedro P.V.P. Diniz
JNJacqueline Noble
Jacqueline Noble
ZHZarah Hedge
Zarah Hedge
Introduction: The San Diego Humane Society annually supports thousands of kittens, many of whom are orphaned and high risk for illness and death. Failure of passive transfer (FPT) is presumed common in orphaned neonatal kittens lacking colostrum-derived antibodies. Although subcutaneous plasma supplementation can increase circulating antibodies, its impact on survival and illness in shelter populations remains uncertain. Objective: To assess the effect of plasma supplementation at shelter intake on (1) hazard of death within 30 days and (2) time to onset of common clinical signs in orphaned neonatal kittens. Methods: Retrospective cohort study of medical records from February to August 2015. Allocation of plasma supplementation was non-randomized, based on operational constraints. Kittens ≤ 4 weeks at intake were eligible; exclusions were death or euthanasia within 24 h of intake or missing weights within 14 days. Exposure was standardized as 3-mL of subcutaneous plasma administered within 24 h of intake. Outcomes were death within 30 days of shelter intake and time to first onset of diarrhea, upper respiratory signs, hypothermia, anorexia, weight loss, or neurological signs. Results: Cohort included 544 kittens (Plasma-Supplemented [PS] group n = 193; Control group n = 351). Review of Kaplan–Meier curves suggested early differences in survival rates between groups (days 3–11); however, after accounting for demographics and onset of clinical signs, plasma supplementation was not statistically associated with decreased mortality risk at any time during the first 30 days after intake. Strongest mortality predictors were intake weight, average weight gain, and onset of weight loss. Plasma supplementation demonstrated a significant impact on delaying onset of diarrhea and weight loss, but no other signs. Conclusion: Subcutaneous plasma supplementation at intake did not reduce mortality risk but delayed onset of key morbidities. Intake weight and weight gain were the most important survival predictors, highlighting importance of nutrition and suggesting that plasma supplementation may reduce common clinical manifestations in shelter populations.